The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid ID: ALA348270
PubChem CID: 9948506
Max Phase: Preclinical
Molecular Formula: C19H17NO3
Molecular Weight: 307.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)C1=C(C(=O)Nc2ccc(-c3ccccc3)cc2)CCC1
Standard InChI: InChI=1S/C19H17NO3/c21-18(16-7-4-8-17(16)19(22)23)20-15-11-9-14(10-12-15)13-5-2-1-3-6-13/h1-3,5-6,9-12H,4,7-8H2,(H,20,21)(H,22,23)
Standard InChI Key: KKMNLDWJDASMGY-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
2.4000 0.0833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2250 0.0583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9375 0.7583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2125 1.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6167 -0.6667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6542 0.7625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0917 -0.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0250 1.6833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4417 -0.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9167 -0.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6625 -1.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6917 -0.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6792 2.1708 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9000 -0.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1417 0.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8667 0.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8375 -1.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1250 -0.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3417 -0.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3042 -1.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1292 -1.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1667 -0.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5625 -0.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 3 1 0
5 2 1 0
6 2 2 0
7 11 2 0
8 4 2 0
9 5 1 0
10 7 1 0
11 17 1 0
12 16 2 0
13 4 1 0
14 1 1 0
15 3 1 0
16 9 1 0
17 9 2 0
18 14 1 0
19 10 1 0
20 10 2 0
21 20 1 0
22 19 2 0
23 21 2 0
18 15 1 0
12 7 1 0
23 22 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 307.35Molecular Weight (Monoisotopic): 307.1208AlogP: 3.86#Rotatable Bonds: 4Polar Surface Area: 66.40Molecular Species: ACIDHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.31CX Basic pKa: ┄CX LogP: 3.81CX LogD: 0.39Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.90Np Likeness Score: -0.50
References 1. Leban J, Saeb W, Garcia G, Baumgartner R, Kramer B.. (2004) Discovery of a novel series of DHODH inhibitors by a docking procedure and QSAR refinement., 14 (1): [PMID:14684297 ] [10.1016/j.bmcl.2003.10.021 ] 2. Leban J, Kralik M, Mies J, Gassen M, Tentschert K, Baumgartner R.. (2005) SAR, species specificity, and cellular activity of cyclopentene dicarboxylic acid amides as DHODH inhibitors., 15 (21): [PMID:16143532 ] [10.1016/j.bmcl.2005.07.053 ] 3. Leban J, Kralik M, Mies J, Baumgartner R, Gassen M, Tasler S.. (2006) Biphenyl-4-ylcarbamoyl thiophene carboxylic acids as potent DHODH inhibitors., 16 (2): [PMID:16246558 ] [10.1016/j.bmcl.2005.10.011 ] 4. Mancini RS, Barden CJ, Weaver DF, Reed MA.. (2021) Furazans in Medicinal Chemistry., 64 (4.0): [PMID:33569941 ] [10.1021/acs.jmedchem.0c01901 ]